LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
LipUm has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
LipUm's investors include Almi Invest, Horizon Europe, EISMEA, Eurostars, Flerie Invest.
LipUm is headquartered in Umeå, Sweden.
LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
LipUm is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LipUm — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/lipum. Accessed September 29, 2026.
VCBacked. (2026). LipUm — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/lipum
{{cite web |title=LipUm — Funding & Investors |url=https://www.vcbacked.co/company/lipum |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated